Skip to Main content Skip to Navigation
Journal articles

Fungal infections in HIV/AIDS

Abstract : Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS. Systemic infections are mainly with Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma capsulatum (histoplasmosis), and Talaromyces (Penicillium) marneffei (talaromycosis). The incidence of systemic fungal infections has decreased in people with HIV in high-income countries because of the widespread availability of antiretroviral drugs and early testing for HIV. However, in many areas with high HIV prevalence, patients present to care with advanced HIV infection and with a low CD4 cell count or represent with persistent low CD4 cell counts because of poor adherence, resistance to antiretroviral drugs, or both. Affordable, rapid point-of-care diagnostic tests (as have been developed for cryptococcosis) are urgently needed for pneumocystosis, talaromycosis, and histoplasmosis. Additionally, antifungal drugs, including amphotericin B, liposomal amphotericin B, and flucytosine, need to be much more widely available. Such measures, together with continued international efforts in education and training in the management of fungal disease, have the potential to improve patient outcomes substantially.
Document type :
Journal articles
Complete list of metadatas

Cited literature [95 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01574426
Contributor : Inserm Cic1424 Centre d'Investigation Clinique Antilles Guyane <>
Submitted on : Monday, August 14, 2017 - 2:35:06 PM
Last modification on : Wednesday, August 7, 2019 - 3:34:12 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Andrew Limper, Antoine Adenis, Thuy Le, Thomas Harrison. Fungal infections in HIV/AIDS. The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2017, ⟨10.1016/S1473-3099(17)30303-1⟩. ⟨inserm-01574426⟩

Share

Metrics

Record views

187